A

Atossa Therapeutics
D

ATOS

1.76000
USD
-0.14
(-7.37%)
مغلق
حجم التداول
3,396
الربح لكل سهم
-4
العائد الربحي
-
P/E
-0
حجم السوق
17,555,995
أصول ذات صلة المقالات
المزيد

العنوان: Atossa Therapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.